Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
By Route of Administration : Oral Injection The market from the oral segment is projected to gain momentum through 2032 on account of the introduction of oral formulations, which has revolutionized the market by providing a more convenient and patient-friendly option for diabetes management
How soon will I see results with Retatrutide
Want to see the Rejuv difference
If you have lost 20 percent of body weight at 8mg and your appetite is well-controlled, there is no clinical reason to escalate further
Zepbound (tirzepatide) is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA in November 2023 for chronic weight management in adults with obesity or overweight with weight-related comorbidities
US$ 27.55
US$ 29.13
US$ 28.65
